EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fluorescence-Guided Surgery for Gliomas: Past, Present, and Future

Benjamin Rodriguez iD, Cole S Brown iD, Jhair Alejandro Colan, Jack Yin Zhang, Sakibul Huq, Daniel Rivera, Tirone Young iD, Tyree Williams iD, Varun Subramaniam iD, Constantinos Hadjipanayis

Cancers · 30.05.2025 · 17 (11) · 1837

DOI: 10.3390/cancers17111837 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.05.2025. Verfasst von Benjamin Rodriguez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Glioblastoma (GBM) is the most common primary malignant central nervous system tumor, accounting for 50.9% of malignant CNS diagnoses and carrying a median survival of 15 months despite maximal standard therapy. High recurrence rates are driven by residual infiltrative tumor cells at the resection margin. Fluorescence-guided surgery (FGS) has emerged as a key innovation to improve intraoperative tumor visualization and maximize the extent of resection (EOR). This review examines the historical development, current clinical applications, and future directions of FGS in GBM surgery.

Methods

A comprehensive literature review was conducted, covering the evolution of fluorophores (fluorescein, indocyanine green [ICG], and 5-aminolevulinic acid [5-ALA]), visualization technologies (wide- and narrow-field modalities), therapeutic adjuncts (photodynamic and sonodynamic therapies), and clinical adoption patterns and outcomes.

Results

Early intraoperative fluorescence using fluorescein dates to 1947. ICG angiography has broad surgical utility, while 5-ALA received FDA approval in 2017, with phase III trials demonstrating gross total resection rates of 65% versus 36% with white-light surgery. Adjunct technologies—3D exoscopes, FGS-compatible loupes, and quantitative spectroscopy probes—enhance detection of residual tumor. Preliminary studies of intraoperative photodynamic and sonodynamic therapies show feasibility and potential survival benefits. Global adoption of 5-ALA FGS exceeds 75% among surveyed neurosurgeons.

Conclusions

FGS significantly improves EOR in GBM surgery, translating into better patient outcomes. Ongoing clinical trials and technological refinements—novel fluorophores, quantitative imaging, and therapeutic applications—promise to further optimize tumor visualization and treatment.

Schlagwörter

Stichwörter der Autor:innen

5-ALAfluorescence-guided surgeryglioblastomahigh-grade gliomaintraoperative imaging

Autor:innen und Institutionen

  • Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Sinai BioDesign, Department of Neurosurgery, Mount Sinai, New York, NY 10029, USA.
  • Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
  • Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
  • Brain Tumor Nanotechnology Laboratory, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA.
  • Center for Image-Guided Neurosurgery, Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

ORCID-Profile: Benjamin Rodriguez, Cole S Brown, Tirone Young, Tyree Williams, Varun Subramaniam

Zitieren

APA

Rodriguez, B., Brown, C. S., Colan, J. A., Zhang, J. Y., Huq, S., Rivera, D., Young, T., Williams, T., Subramaniam, V., & Hadjipanayis, C. (2025). Fluorescence-Guided Surgery for Gliomas: Past, Present, and Future. Cancers, 17(11), 1837. https://doi.org/10.3390/cancers17111837

Vancouver

Rodriguez B, Brown CS, Colan JA, Zhang JY, Huq S, Rivera D, et al. Fluorescence-Guided Surgery for Gliomas: Past, Present, and Future. Cancers. 2025;17(11):1837. doi:10.3390/cancers17111837

BibTeX
@article{Rodriguez2025,
  author = {Rodriguez, Benjamin and Brown, Cole S and Colan, Jhair Alejandro and Zhang, Jack Yin and Huq, Sakibul and Rivera, Daniel and Young, Tirone and Williams, Tyree and Subramaniam, Varun and Hadjipanayis, Constantinos},
  title = {Fluorescence-Guided Surgery for Gliomas: Past, Present, and Future},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {11},
  pages = {1837},
  doi = {10.3390/cancers17111837}
}
Kostenlos starten →